Study on Clinical Features and the Reproductive Hormonal Profile in Normal, Overweight and Obese Polycystic Ovarian Syndrome Women of Selected Age Group

Jump To References Section


  • Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore - 641 043 ,IN
  • Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore - 641 043 ,IN



Polycystic Ovarian Syndrome, Acne, Hirsutism, Testosterone And Estradiol


The objectives of the present study are to compare the clinical features among normal and PCOS women and to assess the reproductive hormonal profile of normal and PCOS women of the overweight and obese group. The normal and PCOS women were subdivided into three groups, group 1-healthy women with BMI 18.5- 24.99 (n=10), group 2 PCOS with BMI 25-29.9 (n=11) and group 3 PCOS with BMI >29.9 (n=10). The prevalence of menstrual irregularity, acne, hirsutism and obesity are the major clinical manifestations of PCOS women than the normal women of the same age group. The levels of testosterone increased and estradiol level decreased in the PCOS subjects of both overweight and obese groups. These observations in the study strongly support the presence of hyperandrogenism in PCOS women and favors all the associated clinical features. The results also clearly demonstrated the increase in body mass index reflecting a negative impact on the reproductive outcome in PCOS.


Download data is not yet available.


Metrics Loading ...



How to Cite

S., V., & S., A. (2021). Study on Clinical Features and the Reproductive Hormonal Profile in Normal, Overweight and Obese Polycystic Ovarian Syndrome Women of Selected Age Group. The Indian Journal of Nutrition and Dietetics, 58(S1), 128–134.



Original Articles



Soni, N.R. Current management on PCOS (Polycystic Ovary Syndrome) / Stein-Leventhal syndrome. Investig. Gynecol. Res. Womens Heal. (IGRWH)., 2017, 1, 46- 48. DOI: 10.31031/ IGRWH.2017.01.000511 DOI:

Hart, R. and Doherty, D.A. The potential implications of a PCOS diagnosis on a woman's longterm health using data linkage. J. Clin. Endocrinol. Metabol., 2015, 100, 911-919. DOI: 10.1210/ jc.2014-3886 DOI:

Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Pugeat, M. and Yildiz, B. European survey of diagnosis and management of the polycystic ovary syndrome: Results of the ESE PCOS special interest group's questionnaire. Eur. J. Endocrinol., 2014, 171, 489 - 498. DOI:

Qureshi, S.S., Gupta J.K., Shah, K. and Upmanyu, E. Prevalence and risk factor of polycystic ovarian syndrome, As. J. Pharma. Clin. Res.., 2016, l9, 23-25. journals/index.php/ajpcr/article/view/10202.

Begum, M.R., Ehsan, M., Begum, M.S., Khan, F., Baby, H.A., Siddiqui, M. and Quadir, E. Beneficial effects of addition of glucocorticoid during induction of ovulation by letrozole in polycystic ovarian syndrome, J. South Asian Federat. Obstet. Gynecol., 2012, 4, 85- 89. DOI: 10.5005/jp-journals-10006-1180 DOI:

Matsumoto, A.M. and Bremner, W.J. Serum testosterone assays-accuracy matters, J. Clin.Endocrinol. Metabol., 2004, 89, 520 - 524. DOI:

Zucchelli, G.C., Piro, M.A., Simonini, N.,Giannessi, D. and Malvano, R. Direct radioimmunoassay of estradiol in serum extracts, Eur. J. Nuclear Med., 1977, 2, 193 -202. DOI:

Ramanand, S.J., Ghongane, B.B., Ramanand, J.B., Patwardhan, M.H., Ghanghas, R.R. and Jain, S.S. Clinical characteristics of polycystic ovary syndrome in Indian women. Ind. J. Endocrinol. Metabol., 2013, 17, 138-145. DOI:

Pundir, J., Psaroudakis, D., Savnur, P., Bhide, P., Sabatini, L., Teede, H., Coomarasamy A. and Thangaratinam, S. Inositol treatment of an ovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials, BJOG- An Int. J. Obstet. Gynaecol., 2018, 125, 299 - 308. doi: 10.1111/1471-0528.14754. DOI:

Sulaiman, A.H., Al-Farsi, Y.M., Al-Khaduri, M., Waly, M.I. and Al-Adawi, S. Psychological burden among women with polycystic ovarian syndrome in Oman: A case–control study, Int. J. Women's Health, 2017, 9, 897-904. DOI: 10.2147/IJWH.S145383 DOI:

Tanwar, S. and Khilnani, G.D. Effects on menstruation pattern of polycystic ovarian syndrome (PCOS) cases in a comparative study of metformin and pioglitazone. IOSR J. Dent. Med. Sci., 2016, 15, 1-29.DOI: 10.9790/0853-1504052935

Shareef, A.P., Prasad, V.S. and Kaviarasan, P.K. Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study, Int. J. Res. Med. Sci., 2018, 6, 899- 903. DOI: DOI:

Singh, A., Vijaya, K. and Sai Laxmi, K. Prevalence of polycystic ovarian syndrome among adolescent girls: A prospective study, Int. J. Reproduct., Contracep., Obstet. Gynecol., 2018, 7, 4375 - 4378. DOI: DOI:

Belosi, C., Selvaggi, L., Apa, R., Guido, M., Romualdi, D., Fulghesu, A.M. and Lanzone, A. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Human Reproduct., 2006, 21, 3108 - 3115. DOI:

Abdullah, Z., Masood, Q., Hassan I., Kirmani, O. Hormonal Profile and polycystic ovaries in women with polycystic ovaries, Ind. J. Dermatol. Venereol. Leprol., 2013, 79, 422-424. DOI:

Hussein, R.N., Al-Hamdi, K.I. and Mansour, A. The contribution of new areas to the total hirsutism scores in basrah hirsute women, Diseas., 2017, 5, 2- 9. DOI:

Hunter, M.H. and Carek, P. Evaluation and treatment of women with hirsutism, Am. Fami. Physi., 2003, 67, 2565-2572

Spritzer, P.M., Barone, C.R. and de Oliveira,F.B. Hirsutism in polycystic ovary syndrome: pathophysiology and management”, Curr. Pharma. Design, 2016, 22, 5603. DOI:

Pawar M. U, S. S. Percentage of Hirsutism with and without PCOS in women of Amravati Region, Maharashtra, India, Int. J. Sci. Res., 2014, 3, 1258- 1261.

Wijeyaratne, C.N., Balen, A.H., Barth, J.H. and Belchetz, P.E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin. Endocrinol (Oxford)., 2002, 57, 343 - 350. DOI:

Subha, R. and Tharini, G. K. Clinical Evaluation of hirsutism in South India, Int. J. Res. Dermatol., 2018, 4, 495-500. DOI:

Pasquali, R. Contemporary approaches to the management of polycystic ovary syndrome. Therap. Adv. Endocrinol. Metabol., 2018, 123-134. DOI:

Ollila, M.M.E., West, S., Keinänen-Kiukaanniemi, J., Jokelainen, J., Auvinen, K., Puukka, A., Ruokonen, M.R., Järvelin, J.S., Franks, T. and Piltonen, T.T. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study, Human Reproduct., 2017, 32, 423-431. DOI:

Baptiste, C.G., Battista, M.C., Trottier, A. and Baillargeon, J.P. Insulin and hyperandrogenism in women with polycystic ovary syndrome, The J. Ster. Biochem. Molecu. Biol., 2010, 122, 42-52. DOI:

Zhang, J., Bao, Y., Zhou, X. and Zheng, L. Polycystic ovary syndrome and mitochondrial dysfunction, Reproduc. Biol. Endocrinol., 2019, 17, 67. doi: 10.1186/s12958-019-0509-4 DOI:

Ndefo, U.A., Eaton, A. and Green, M.R. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. : A Peer-Rev. J. Formul. Manag., 2013, 38, 336-355.

Most read articles by the same author(s)